SCHEMBL31064451

SCHEMBL31064451

CN[C@H](C)c1ncc(C2CC2)cc1F

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 1/20 0.42
S1PR3 Q99500 1/20 0.42
GPR55 Q9Y2T6 1/20 0.38
DHODH Q02127 3/20 0.37
ADRB3 P13945 1/20 0.37
ADRA1D P25100 1/20 0.37
SLC6A4 P31645 1/20 0.37
ABAT P80404 1/20 0.37
TMEM97 Q5BJF2 1/20 0.37
MAPK1 P28482 1/20 0.33
CNR1 P21554 1/20 0.32
CNR2 P34972 1/20 0.32
ACACB O00763 6/20 0.32
HRH1 P35367 1/20 0.32
HRH4 Q9H3N8 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32
KDM4E B2RXH2 1/20 0.32
GPR139 Q6DWJ6 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL31064255 0.98 S1PR1 (0.41) S1PR1S1PR3GPR55DHODHADRB3
SCHEMBL21139636 0.85 S1PR1 (0.44) S1PR1S1PR3GPR55DHODHADRB3
Hydrochloric Acid SCHEMBL31064700 0.82 S1PR1 (0.39) S1PR1S1PR3GPR55DHODHADRB3
SCHEMBL31064441 0.82 S1PR1 (0.39) S1PR1S1PR3GPR55DHODHADRB3
SCHEMBL31064639 0.81 S1PR1 (0.41) S1PR1S1PR3GPR55DHODHADRB3
SCHEMBL24468301 0.76 JAK3 (0.34) SLC6A4
SCHEMBL17445189 0.76 JAK3 (0.34) SLC6A4
SCHEMBL29686056 0.76 JAK3 (0.34) SLC6A4
SCHEMBL31187846 0.76 ACACB (0.41) S1PR3ACACB
SCHEMBL25928002 0.73 KDM4E (0.37) S1PR1S1PR3GPR55DHODHADRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4688785-A1 5-AMINO-6, 8-DIHYDRO-1H-FURO [3, 4-D] PYRROLO [3, 2-B] PYRIDINE-2-CARBOXAMIDE DERIVATIVES AS MTA-COOPERATIVE INHIBITORS OF PRMT5 Beone Medicines I GmbH (CH) 2026-02-11 EP disclosed
US-20240368177-A1 5-AMINO-6,8-DIHYDRO-1H-FURO[3,4-d]PYRROLO[3,2-b]PYRIDINE-2-CARBOXAMIDE DERIVATIVES AS MTA-COOPERATIVE INHIBITORS OF PRMT5 BEIGENE SWITZERLAND GMBH (CH) 2024-11-07 US disclosed
WO-2024199255-A1 5-AMINO-6, 8-DIHYDRO-1H-FURO [3, 4-d] PYRROLO [3, 2-b] PYRIDINE-2-CARBOXAMIDE DERIVATIVES AS MTA-COOPERATIVE INHIBITORS OF PRMT5 BEIGENE SWITZERLAND GMBH (CH) 2024-10-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240368177-A1 5-AMINO-6,8-DIHYDRO-1H-FURO[3,4-d]PYRROLO[3,2-b]PYRIDINE-2-CARBOXAMIDE DERIVATIVES AS MTA-COOPERATIVE INHIBITORS OF PRMT5 PRMT5, PRMT6, PRMT1 S1PR1 3736/4885S1PR3 3423/4885GPR55 1766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.